Insiders · DTIL

DTIL insider transactions

Precision BioSciences Inc. (DTIL) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for DTIL

• 3d
  SEC Form 4 filed by Director Brown Melinda

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 3d
  SEC Form 4 filed by Director Frankel Stanley

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 3d
  SEC Form 4 filed by Director Germano Geno J

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 3d
  SEC Form 4 filed by Director Pire Shari Lisa

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 3d
  SEC Form 4 filed by Director Buehler Kevin

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 4d
  SEC Form 4 filed by Chief Research Officer Smith J. Jefferson

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 4d
  SEC Form 4 filed by Chief Financial Officer Kelly John Alexander

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 4d
  SEC Form 4 filed by General Counsel and Secretary Scimeca Dario

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 4d
  SEC Form 4 filed by President and CEO Amoroso Michael

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 17d
  Director Buehler Kevin converted options into 21,000 shares, increasing direct ownership by 75% to 49,137 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 17d
  Director Frankel Stanley converted options into 21,000 shares, increasing direct ownership by 108% to 40,478 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 17d
  Director Brown Melinda converted options into 21,000 shares, increasing direct ownership by 90% to 44,346 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 17d
  Director Pire Shari Lisa converted options into 21,000 shares, increasing direct ownership by 150% to 35,028 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 17d
  Director Germano Geno J converted options into 21,000 shares, increasing direct ownership by 88% to 44,883 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 108d
  President and CEO Amoroso Michael converted options into 67,797 shares and sold $78,947 worth of shares (20,559 units at $3.84), increasing direct ownership by 24% to 243,392 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 108d
  Chief Financial Officer Kelly John Alexander converted options into 27,584 shares and sold $31,292 worth of shares (8,149 units at $3.84), increasing direct ownership by 18% to 125,883 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 108d
  General Counsel and Secretary Scimeca Dario converted options into 16,667 shares and sold $18,912 worth of shares (4,925 units at $3.84), increasing direct ownership by 26% to 56,457 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 108d
  Chief Research Officer Smith J. Jefferson converted options into 16,667 shares and sold $18,912 worth of shares (4,925 units at $3.84), increasing direct ownership by 11% to 121,926 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 136d
  President and CEO Amoroso Michael converted options into 115,378 shares and sold $145,112 worth of shares (34,799 units at $4.17), increasing direct ownership by 70% to 196,154 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 136d
  General Counsel and Secretary Scimeca Dario converted options into 25,311 shares and sold $35,682 worth of shares (8,854 units at $4.03), increasing direct ownership by 58% to 44,715 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 136d
  Chief Financial Officer Kelly John Alexander converted options into 44,363 shares and sold $61,308 worth of shares (15,213 units at $4.03), increasing direct ownership by 38% to 106,448 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 136d
  Chief Research Officer Smith J. Jefferson converted options into 29,166 shares and sold $41,106 worth of shares (10,200 units at $4.03), increasing direct ownership by 21% to 110,184 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 173d
  Director Germano Geno J bought $14,160 worth of shares (3,000 units at $4.72), increasing direct ownership by 14% to 23,883 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 173d
  Director Frankel Stanley bought $12,690 worth of shares (2,700 units at $4.70), increasing direct ownership by 16% to 19,478 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 173d
  Director Brown Melinda bought $6,864 worth of shares (1,381 units at $4.97), increasing direct ownership by 6% to 23,346 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 215d
  Chief Financial Officer Kelly John Alexander converted options into 3,605 shares and sold $8,456 worth of shares (1,303 units at $6.49), increasing direct ownership by 3% to 77,298 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 215d
  General Counsel and Secretary Scimeca Dario converted options into 1,835 shares and sold $4,316 worth of shares (665 units at $6.49), increasing direct ownership by 4% to 28,258 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 215d
  President and CEO Amoroso Michael converted options into 9,444 shares and sold $22,124 worth of shares (3,409 units at $6.49), increasing direct ownership by 6% to 115,575 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 251d
  Director Frankel Stanley bought $13,419 worth of shares (2,700 units at $4.97), increasing direct ownership by 19% to 16,778 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 257d
  Director Brown Melinda bought $6,846 worth of shares (1,400 units at $4.89), increasing direct ownership by 7% to 21,965 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 334d
  Chief Financial Officer Kelly John Alexander sold $63,163 worth of shares (14,827 units at $4.26), decreasing direct ownership by 17% to 73,485 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 346d
  Director Brown Melinda bought $6,963 worth of shares (1,682 units at $4.14), increasing direct ownership by 9% to 20,565 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 346d
  Director Buehler Kevin bought $21,116 worth of shares (5,076 units at $4.16), increasing direct ownership by 22% to 28,137 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 368d
  Director Germano Geno J converted options into 9,826 shares, increasing direct ownership by 89% to 20,883 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 368d
  Director Pire Shari Lisa converted options into 9,826 shares, increasing direct ownership by 234% to 14,028 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 368d
  Director Buehler Kevin converted options into 9,826 shares, increasing direct ownership by 74% to 23,061 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 368d
  Director Frankel Stanley converted options into 9,826 shares, increasing direct ownership by 231% to 14,078 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 368d
  SEC Form 4 filed by Chief Research Officer Smith J. Jefferson

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 368d
  Director Brown Melinda converted options into 9,826 shares, increasing direct ownership by 108% to 18,883 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 368d
  SEC Form 4 filed by President and CEO Amoroso Michael

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 368d
  SEC Form 4 filed by Chief Financial Officer Kelly John Alexander

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 368d
  SEC Form 4 filed by General Counsel and Secretary Scimeca Dario

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 437d
  Director Buehler Kevin bought $21,122 worth of shares (4,523 units at $4.67), increasing direct ownership by 52% to 13,235 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 437d
  Director Brown Melinda bought $8,735 worth of shares (1,839 units at $4.75), increasing direct ownership by 25% to 9,057 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 438d
  Director Germano Geno J bought $17,225 worth of shares (3,250 units at $5.30), increasing direct ownership by 42% to 11,057 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 439d
  President and CEO Amoroso Michael sold $5,360 worth of shares (964 units at $5.56) and converted options into 3,417 shares, increasing direct ownership by 2% to 109,540 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 459d
  Chief Research Officer Smith J. Jefferson converted options into 519 shares and sold $756 worth of shares (154 units at $4.91), increasing direct ownership by 0.42% to 87,805 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 459d
  General Counsel and Secretary Scimeca Dario converted options into 919 shares and sold $1,336 worth of shares (272 units at $4.91), increasing direct ownership by 3% to 25,000 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 459d
  Chief Financial Officer Kelly John Alexander converted options into 1,702 shares, increasing direct ownership by 2% to 86,256 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 501d
  General Counsel and Secretary Scimeca Dario converted options into 25,312 shares and sold $42,765 worth of shares (8,928 units at $4.79), increasing direct ownership by 206% to 24,353 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 501d
  President and CEO Amoroso Michael converted options into 115,388 shares and sold $172,033 worth of shares (36,838 units at $4.67), increasing direct ownership by 275% to 107,087 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 501d
  Chief Research Officer Smith J. Jefferson converted options into 29,168 shares and sold $49,275 worth of shares (10,287 units at $4.79), increasing direct ownership by 28% to 87,440 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 501d
  Chief Financial Officer Kelly John Alexander converted options into 44,368 shares, increasing direct ownership by 110% to 84,554 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 522d
  Director Germano Geno J bought $16,186 worth of shares (3,605 units at $4.49), increasing direct ownership by 86% to 7,807 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 524d
  Chief Financial Officer Kelly John Alexander bought $10,037 worth of shares (2,113 units at $4.75), increasing direct ownership by 6% to 40,186 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 524d
  Director Buehler Kevin bought $21,082 worth of shares (4,320 units at $4.88), increasing direct ownership by 98% to 8,712 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 525d
  Director Brown Melinda bought $13,723 worth of shares (3,016 units at $4.55), increasing direct ownership by 72% to 7,218 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 563d
  Chief Financial Officer Kelly John Alexander bought $20,280 worth of shares (3,000 units at $6.76), increasing direct ownership by 9% to 38,073 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 579d
  Chief Financial Officer Kelly John Alexander converted options into 3,605 shares, increasing direct ownership by 11% to 35,073 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)
• 579d
  General Counsel and Secretary Scimeca Dario converted options into 1,836 shares and sold $4,816 worth of shares (588 units at $8.19), increasing direct ownership by 19% to 7,969 units (SEC Form 4)

  4 - PRECISION BIOSCIENCES INC (0001357874) (Issuer)